Both in Pharmaceuticals
Liquidia vs Xenon Pharmaceuticals
Over the past year LQDA returned +67.3% and XENE returned −7.0%; their daily moves had a correlation of 0.07.
LQDA +67.3% XENE −7.0%Growth of $1, one year, split-adjusted
| Metric | LQDA | XENE |
|---|---|---|
| Price | $42.20 | $38.23 |
| Market cap | $3.78B | $3.70B |
| Today | +0.84% | +1.62% |
| 1 month | +52.7% | +1.8% |
| 6 months | +5.2% | −33.8% |
| Year to date | +22.4% | −14.7% |
| 1 year | +73.2% | −8.8% |
| Revenue growth (YoY) | +1842.7% | — |
| Gross margin | 93.3% | — |
| Net margin | 43.5% | — |
| P/E (TTM) | 27.3× | — |
| Price / sales | 8.4× | — |
| Net cash | $108.1M | $930.7M |
| Dividend yield | — | — |
| Volatility (60d) | 189.7% | 82.4% |
| Short % of float | 26.2% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).